With regard to other cancer types, altered glycosylation of serum MUC1, a highly sialylated glycoprotein, exhibited potential for the early diagnosis of breast cancer [92] and sialylation of serum MUC1 was also enhanced in colorectal cancer patients [93]. This evidence concerns the gene MUC1 and breast cancer.